Cdk4 inhibitor III

SynDRA canonical compound SYN1954582 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	CDK2 \| CDK4
Mechanism of action	histone lysine methyltransferase inhibitor

All known targets

CDK2
CDK4

Mechanisms of action (all sources)

histone lysine methyltransferase inhibitor

Cross-references

Synonyms

Ryuvidine
CHEMBL290904
2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione
5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole
2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione
AC1Q6BBC
AC1LA59T
2-Methyl-5-p-tolylamino-benzothiazole-4,7-dione
SCHEMBL2169284
GTPL5952
CTK4F8075
CHEBI:92119
AOB6479
MolPort-023-276-509
HMS3269F11
HMS3229E08
ZINC5930916
BDBM50086655
2-METHYL-5-[(4-METHYLPHENYL)AMINO]-4,7-BENZOTHIAZOLEDIONE
AKOS024457195
CCG-206830

Look up Cdk4 inhibitor III in the interactive SynDRA portal →